Articles tagged with 'abjornson' | Hospital for Special Surgery

October

29,

2024

| 21:52 PM America/New_York

Prodisc C may be safe, effective at 24 months for symptomatic cervical disc disease

Healio featuring Celeste Abjornson, PhD

HSS Presents Research at 2023 AAOS Annual Meeting

At this year’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, held March 7 to 11 in Las Vegas, Hospital for Special Surgery (HSS) presented new research on a variety of topics in orthopedic surgery, including studies related to …

Interlaminar stabilization may have edge in elderly with lumbar stenosis

Reuters Health featuring Celeste Abjornson, PhD

	Autoimmune diseases opens in new window
	Education opens in new window
	Events opens in new window
	Foot & Ankle opens in new window
	Hand & Upper Extremity opens in new window
	HSS opens in new window
	Joint Replacement opens in new window
	Lupus opens in new window
	Non-Surgical opens in new window
	Pediatrics opens in new window
	Physiatry opens in new window
	Rehabilitation opens in new window
	Research opens in new window
	Rheumatology opens in new window
	Spine Surgery opens in new window
	Sports Medicine opens in new window

Prodisc C may be safe, effective at 24 months for symptomatic cervical disc disease

HSS Presents Research at 2023 AAOS Annual Meeting

Interlaminar stabilization may have edge in elderly with lumbar stenosis

Connect With Us

Learn More

Information For

Policies

Articles tagged with 'abjornson' | Hospital for Special Surgery

Hospital for Special Surgery - Archive Abjornson

Prodisc C may be safe, effective at 24 months for symptomatic cervical disc disease

HSS Presents Research at 2023 AAOS Annual Meeting

Interlaminar stabilization may have edge in elderly with lumbar stenosis